0001555280-22-000188.txt : 20220613 0001555280-22-000188.hdr.sgml : 20220613 20220613203425 ACCESSION NUMBER: 0001555280-22-000188 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reed Willie M CENTRAL INDEX KEY: 0001601695 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 221013216 MAIL ADDRESS: STREET 1: C/O ZOETIS STREET 2: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_165516685013595.xml FORM 4 X0306 4 2022-06-10 0 0001555280 Zoetis Inc. ZTS 0001601695 Reed Willie M C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 0 0 0 Common Stock 2022-06-10 4 S 0 1855 162.31 D 6782 D The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.30 to $162.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Brenda Santuccio, as Attorney-in-Fact 2022-06-13 EX-24 2 williereedpoamay2022.htm POWER OF ATTORNEY - 2022

POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of Heidi Chen, Christine DiFabio, Salvatore Gagliardi, Lauren Luptak and Brenda Santuccio, each with full power of substitution and re-substitution, as the undersignedTMs true and lawful attorney-in-fact and agent (each of such persons and their substitutes being referred to herein as the Attorney-in-Fact), and grants each Attorney-in-Fact full power to act on behalf of the undersigned and in the undersignedTMs name, place and stead, in any and all capacities, for the purpose of completing and signing, on behalf of the undersigned,
     any Form 3, Form 4 or Form 5 required or permitted to be filed by the undersigned pursuant to Section 16 of the Securities Exchange Act of 1934, as amended (the Exchange Act),
     any Form 144 required to be filed by the undersigned under the Securities Act of 1933, as amended (the Securities Act), and Rule 144 promulgated thereunder, and
     any and all other documents, including, without limitation, Form ID, necessary or desirable to facilitate the filing by the undersigned of Form 144 and forms under Section 16 of the Exchange Act,
with regard to the undersignedTMs ownership of or transactions in securities of Zoetis Inc., including, without limitation, the power to complete and sign any and all amendments to such forms and documents, if any, and to file such forms and documents and amendments thereto with the Securities and Exchange Commission, and to do and perform each and every act and thing requisite or necessary to be done in connection with such forms and documents and amendments thereto, as fully and to all intents and purposes as the undersigned might or could do in person.

The authority of each Attorney-in-Fact under this Power of Attorney shall continue until the undersigned is no longer required to file Form 3, Form 4, Form 5 or Form 144 with regard to the undersignedTMs ownership of or transactions in securities of Zoetis Inc., unless earlier revoked in writing. The authority of each Attorney-in-Fact under this Power of Attorney shall terminate on the date such person is no longer a Zoetis employee. The undersigned acknowledges that each Attorney-in-Fact is not assuming any of the undersignedTMs responsibilities to comply with Rule 144 under the Securities Act or Section 16 of the Exchange Act.

Signature:  /s/Willie M. Reed

Date:       5/20/22